VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Introducing Ventripoint 4.0! 🚀 Dr. Adams is a visionary 👏

<< Previous

Bullboard Posts

Next >>

Comment by jopatcloon Nov 13, 2024 3:47pm

27 Views

Post# 36311012

RE:RE:Introducing Ventripoint 4.0! 🚀 Dr. Adams is a visionary 👏

jopatclo wrote:
jopatclo wrote: Bravo Now 4.0 Europe & Canada

CardioLogic Ltd1,173 followers 1 hour ago

Introducing Ventripoint 4.0! Ventripoint is a groundbreaking cardiac imaging tool that converts echo images into accurate volumes and ejection fractions for all four heart chambers, delivering results with the accuracy of cardiac MRI.

With its new capabilities, Ventripoint 4.0 provides additional insights, including:
3D Tensors: Visualise the direction and magnitude of surface changes.
4D Motion: Simulate a dynamic heart model across the cardiac cycle.
3D Global Strain: Assess longitudinal, circumferential, and total surface area changes.
3D Heat Map: Visualise surface area changes in a new heat map view.
3D Segmentation: Access a detailed polar map for surface area change analysis.
Ventripoint Diagnostics Ltd. hashtagCardiacImaging hashtagInnovation

Media player modal window This modal can be closed by pressing the Escape key or activating the close button.

@cardinal his entire focus every day is Ventripoint. Look for key material news right away

8
about 4 hours ago

@cardinal lol--come on early. buy a few...have a great day...

6
about 4 hours ago

@marcge81 @cardinal what timeframe is " right away "?

2
about 3 hours ago

@napoca @marcge81 i don't think that someone could give you a timeframe for that, but from what I'm aware they are planning a company update

8
about an hour ago

@yudi Thank you @cardinal Look for key material news right away & @napoca they are planning a company update.

very positive wins at this point CardioLogic Ltd Introducing Ventripoint 4.0! Ventripoint is a groundbreaking cardiac imaging tool that converts echo images into accurate volumes and ejection fractions for all four heart chambers, delivering results with the accuracy of cardiac MRI. With its new capabilities, Ventripoint 4.0 provides additional insights, including: 3D Tensors: Visualise the direction and magnitude of surface changes. 4D Motion: Simulate a dynamic heart model across the cardiac cycle. 3D Global Strain: Assess longitudinal, circumferential, and total surface area changes. 3D Heat Map: Visualise surface area changes in a new heat map view. 3D Segmentation: Access a detailed polar map for surface area change analysis. Now That V4.0 Europe V4.0 ok & Canada The BEST automation and analysis of the PLANET GEN3EHO https://ascendcv.com/ (Ventripoint - The integration of Gen3Echo with Ventripoint’s innovative application of AI to echocardiography provides tremendous value to pediatric and adult echocardiographers in caring for their most complex patients.) I think they know more about the Ventripoint tech than the whiners on this board. Something could happen anytime real fast! FDA 4.0 It will happen, but not in a way we originally hoped. No investor is happy with the current outcome. You either wait or move on. Dr. Adams is a visionary with Ventripoint FDA V4.0 and Sales at any time now Insiders know! #vpt,

good comment @hassy dont write off 2024 yet. May not be the "break out year" that we are all looking for, but sales are coming in and having a "record" year in sales is not a difficult bar to hit.

 		@JohnnyUtah Thank you for your sacrifice Rocket, I'm also not really buying much these days, until I see some forward progress, it will remain a hold for me. 
 		5
from #vpt,  		about an hour ago

 				 
@hassydont write off 2024 yet. May not be the "break out year" that we are all looking for, but sales are coming in and having a "record" year in sales is not a difficult bar to hit.